Aminoglycosides Market Surges Amidst Escalating Animal Disease Outbreaks Is Supporting Development Across The Aminoglycosides Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Aminoglycosides Market Become By 2030 Compared To 2026?

The aminoglycosides market size has demonstrated significant expansion in recent years. It is projected to increase from $1.91 billion in 2025 to $2.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to several factors, including a high incidence of abdominal and urinary tract infections, the widespread adoption of broad-spectrum antibiotics, conventional manufacturing processes, limited regulatory oversight in veterinary applications, and strong demand within ophthalmic solutions.

The aminoglycosides market is projected to experience robust expansion over the coming years, reaching a valuation of $2.56 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period can be ascribed to several factors, including heightened research and development efforts in targeted aminoglycoside therapies, increasing public awareness of antibiotic resistance, the widespread adoption of advanced drug delivery systems, the expanding veterinary healthcare market, and the growing application of personalized medicine. Key trends expected within the forecast timeframe encompass the increasing prevalence of gram-negative infections, a rise in the veterinary utilization of aminoglycosides, the ongoing development of novel aminoglycoside derivatives, a noticeable shift towards injectable and targeted formulations, and the broadening scope of ophthalmic and inhalation applications for these drugs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8515&type=smp

What Major Growth Factors Are Impacting The Aminoglycosides Market?

A significant factor poised to boost the expansion of the aminoglycosides market is the growing number of animal disease outbreaks. An animal disease is defined as any condition that disrupts an animal’s normal health, affecting or altering its essential functions. Aminoglycosides, including amikacin and gentamicin, are frequently utilized in veterinary care. For example, in July 2025, GOV.UK, a UK government agency, indicated a rise in laboratory-confirmed leptospirosis cases in England, from 70 in 2023 to 102 in 2024, marking a 45.7% increase. Additionally, 890 cases of pasteurellosis were recorded in 2024, an increase from 815 cases in 2023. Consequently, the increasing occurrences of animal disease outbreaks will continue to fuel the growth of the aminoglycosides market.

Aminoglycosides Market Driver: Pet Ownership Surge Fuels Aminoglycosides Market Expansion

The rising number of pet owners is projected to stimulate the expansion of the aminoglycosides market in the future. Pet ownership involves housing and looking after animals, commonly known as pets, within one’s residence. A surge in pet ownership boosts the aminoglycosides market by expanding the consumer base, promoting a focus on preventive pet healthcare, and encouraging greater investment in veterinary pharmaceuticals to meet the varied health requirements of companion animals. For instance, in March 2023, Improve International, a US-based veterinary educational resource, reported that the UK has 38 million pets across 16.2 million households, representing approximately 57% of all households. Thus, the growing trend of pet ownership is propelling the aminoglycosides market’s growth.

How Does Segment Analysis Break Down The Aminoglycosides Market Structure?

The aminoglycosides market covered in this report is segmented –

1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products

2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral

3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases

What Trends Are Affecting The Growth Of The Aminoglycosides Market?

Leading firms within the aminoglycosides market are concentrating on creating advanced solutions, such as enhanced manufacturing techniques and improved formulation processes, aiming to satisfy the growing need for highly effective, next-generation antibiotics that can combat resistant bacterial infections. Such advancements in processes boost the purity, stability, and therapeutic effectiveness when contrasted with conventional aminoglycoside production approaches. As an illustration, in February 2024, the Indian pharmaceutical company, Cipla Limited, obtained approval from the Central Drugs Standard Control Organization (CDSCO) within India for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic. This particular antibiotic is specifically prescribed for addressing complicated urinary tract infections (cUTIs), which includes pyelonephritis.

Who Are The Prominent Players Across The Aminoglycosides Market?

Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience Limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Allergan PLC, Bristol Myers Squibb Company

Access The Complete Aminoglycosides Market Report:

https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report

Which Region Commands The Largest Share Of The Aminoglycosides Market?

Asia-Pacific was the largest region in the aminoglycosides market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Aminoglycosides Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=8515&type=smp

Browse Through More Reports Similar to the Global Aminoglycosides Market 2026, By The Business Research Company

Aminoglycosides Market Report 2026

https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report

Amino Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/amino-acid-global-market-report

Bionematicides Market Report 2026

https://www.thebusinessresearchcompany.com/report/bionematicides-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795